TG and neoplasm: Groups of mice were subcutaneously administered 1 × 106 CT26 cells expressing HER2/neu (HER2/CT26 cells), and 100 μg/kg of Tg was intraperitoneally injected daily starting when tumor sizes reached 50-100 mm3.